Clinuvel Pharmaceuticals Ltd (ASX:CUV)
A$ 13.04 -0.11 (-0.84%) Market Cap: 652.79 Mil Enterprise Value: 469.80 Mil PE Ratio: 18.68 PB Ratio: 3.21 GF Score: 90/100

Full Year 2024 Clinuvel Pharmaceuticals Ltd Earnings Call Transcript

Aug 29, 2024 / 08:00AM GMT
Release Date Price: A$15.41 (+10.86%)
Operator

Thank you for joining us for Clinuvel's full-year results investor presentation. Please note that this webinar is being recorded and will be uploaded onto Clinuvel's website. I'll now hand over to Malcolm Bull to begin the presentation. I'll now hand over to Malcolm onboard to begin the presentation.

Malcolm Bull
Clinuvel Pharmaceuticals Ltd. - Head of Investor Relations

Thank you, Verity, and it's a pleasure to be doing this webinar through Monsoon Communications again. Welcome to all 170 participants on the line from all points of the globe, Australia, New Zealand, Europe and United States. You represent existing and interested institutional shareholders, analysts, bankers and valued private investors.

Whilst this webinar is intended for shareholders and analysts, we even have a potential competitor interested to hear about our results and operations. I should say that whilst we protect the interests of shareholders and do not divulge sensitive commercial and technological information, we welcome Mr. [SBJ].

I'd now like to introduce

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot